Sanofi SA (NASDAQ:SNY)
| 52.15 BATS BZX Real-Time Price As of 11:45am ET |  +0.22 / +0.42%Today’s Change | 44.76 Today|||52-Week Range 55.00 | +7.33% Year-to-Date |
Latest SNY News | Press Releases
| Is Sanofi a Good Buy in 2021? 6:20am / MotleyFool.com - Paid Partner Content | Could AstraZeneca and Sanofi Win Big in RSV? May 08 / MotleyFool.com - Paid Partner Content |
| Covenant Partners, LLC Buys JPMorgan Chase, U.S. ... 2:38am / GuruFocus News - Paid Partner Content | Regeneron (REGN) Q1 Earnings Beat on Strong Eylea & Dupixent May 06 / Zacks.com - Paid Partner Content |
| Novavax's (NVAX) Q1 Loss Widens, Revenues Beat, Shares Down May 11 / Zacks.com - Paid Partner Content | Why Regeneron's Q1 Results Looked Great Despite Its Revenue Miss May 06 / MotleyFool.com - Paid Partner Content |
| Amicus' (FOLD) Q1 Loss Wider Than Expected, Sales Up Y/Y May 11 / Zacks.com - Paid Partner Content | Global Blood's (GBT) Q1 Earnings Miss, Revenues Rise Y/Y May 06 / Zacks.com - Paid Partner Content |
| Biden's Budget May Boost These 3 Biotechs May 10 / MotleyFool.com - Paid Partner Content | Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates May 05 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 51.93 |
| Today’s open | 51.72 |
| Day’s range | 51.72 - 52.20 |
| Volume | 16,411 |
| Average volume (3 months) | 2,243,402 |
| Market cap | $129.6B |
Data as of 11:45am ET, 05/12/2021
Growth & Valuation
| Earnings growth (last year) | +330.16% |
| Earnings growth (this year) | +6.40% |
| Earnings growth (next 5 years) | +6.82% |
| Revenue growth (last year) | +1.61% |
| P/E ratio | 8.8 |
| Price/Sales | 2.98 |
| Price/Book | 1.68 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +1.34 | +1.75% |
| AZNAstraZeneca | +0.82 | +1.52% |
| BMYBristol-Myers Squibb | +0.70 | +1.09% |
| GSKGlaxoSmithKline | +0.41 | +1.07% |
Data as of 11:45am ET, 05/12/2021
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $0.70 |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $14.0B |
| Net profit margin | 34.17% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
